Abstract | OBJECTIVE: METHODS: Five mg of olopatadine hydrochloride (Allerock) was administered to the subjects twice daily. The severity of the pruritus and the scratch scars were scored before, and then 2 weeks and 4 weeks after, commencement of treatment. The severity of the pruritus during the day and night was measured by using a visual analogue scale (VAS), and a daily 'itch score' was recorded in an 'itch diary.' RESULTS: The itch scores for both day and night, as well as the scratching scores, the VAS values and the 'itch score,' significantly decreased after administration of olopatadine. The VAS value was significantly correlated with the itch scores and patient responses in the medical interview. Statistical analysis showed that there was a prompt alleviation of the pruritus in urticaria a day after administration, followed by asteatotic dermatitis and atopic dermatitis, in the order of improvement, within the next several days. CONCLUSION:
|
Authors | Mariko Niide, Yukari Okubo, Ryokichi Irisawa, Ryoji Tsuboi |
Journal | Arerugi = [Allergy]
(Arerugi)
Vol. 55
Issue 10
Pg. 1327-36
(Oct 2006)
ISSN: 0021-4884 [Print] Japan |
PMID | 17072113
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antipruritics
- Dibenzoxepins
- Olopatadine Hydrochloride
|
Topics |
- Adult
- Antipruritics
(therapeutic use)
- Dermatitis, Atopic
(drug therapy, physiopathology)
- Dibenzoxepins
(therapeutic use)
- Drug Administration Schedule
- Female
- Humans
- Male
- Middle Aged
- Olopatadine Hydrochloride
- Pruritus
(drug therapy, physiopathology)
|